Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide

Respiration

Volumn 84, Issue 2, 2012, Pages 144-149

  Langenskiöld, Elisabeth ^a   Bonetti, Alessandro ^b   Fitting, Jean William ^a   Heinzer, Raphaël ^a   Dudler, Jean ^c   Spertini, François ^a   Lazor, Romain ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Private Practice   (Switzerland)

^c Hopital Cantonal de Fribourg   (Switzerland)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

Cyclophosphamide; Diaphragm; Respiratory paralysis; Rituximab; Shrinking lung syndrome; Sj gren syndrome; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE; RITUXIMAB;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG EFFICACY; DYSPNEA; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LIVER TOXICITY; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; NAUSEA AND VOMITING; NEPHROTOXICITY; POLYARTHRITIS; PRIORITY JOURNAL; SHRINKING LUNG SYNDROME; THORAX PAIN; VITAL CAPACITY;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; CHEST PAIN; CYCLOPHOSPHAMIDE; DRUG MONITORING; DRUG THERAPY, COMBINATION; DYSPNEA; FEMALE; HUMANS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLEURA; PLEURISY; RESPIRATORY FUNCTION TESTS; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TREATMENT OUTCOME;

EID: 84864877153     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000334947     Document Type: Article

References (33)

1. Toya SP, Tzelepis GE: Association of the shrinking lung syndrome in systemic lupus erythematosus with pleurisy: a systematic rev iew. Semin Art hritis R heum 2009; 39: 30-37.
2. Karim MY, Miranda LC, Tench CM, Gordon PA, D'Cruz DP, Khamashta MA, Hughes GR: Presentation and prognosis of the shrinking lung syndrome in systemic lupus erythematosus. Semin Arthritis Rheum 2002; 31:289-298.
3. Pego-Reigosa JM, Medeiros DA, Isenberg DA: Respiratory manifestations of systemic lupus erythematosus: old and new concepts. Best Pract Res Clin R heumatol 2009; 23: 469-480.
4. Ahmed S, Herrick A, O'Driscoll BR: Shrinking lung syndrome in patients without systemic lupus erythematosus: comment on the concise communication by Tavoni et al. Arthritis R heum 2001; 44: 243-245.
5. Scire CA, Caporali R, Zanierato M, Mojoli F, Braschi A, Montecucco C: Shrinking lung syndrome in systemic sclerosis. Arthritis Rheum 2003; 48: 2999-3000.
6. Tavoni A, Vitali C, Cirigliano G, Frigelli S, Stampacchia G, Bombardieri S: Shrinking lung in primary Sjögren's syndrome. Arthritis Rheum 1999; 42:2249-2250.
7. Warrington KJ, Moder KG, Brutinel WM: The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000; 75: 467-472.
8. Gibson CJ, Edmonds JP, Hughes GR: Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977; 63:926-932.
9. Hawkins P, Davison AG, Dasgupta B, Moxham J: Diaphragm strength in acute systemic lupus erythematosus in a patient with paradoxical abdominal motion and reduced lung volumes. Thorax 2001; 56: 329-330.
10. Hoffbrand BI, Beck ER: 'Unexplained' dyspnoea and shrinking lungs in systemic lupus erythematosus. Br Med J 1965;i:1273-1277.
11. Laroche CM, Mulvey DA, Hawkins PN, Wal-port MJ, Strickland B, Moxham J, Green M: Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989; 71: 429-439.
12. Hardy K, Herry I, Attali V, Cadranel J, Similowski T: Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001; 119:1274-1277.
13. Al-Raqum HA, Uppal SS, Al-Mutairy M, Kumari R: Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti. Clin Rheumatol 2006; 25:412-414.
14. Wilcox PG, Stein HB, Clarke SD, Pare PD, Pardy RL: Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus er ythematosus. Chest 1988; 93: 352-358.
15. Rubin LA, Urowitz MB: Shrinking lung syndrome in SLE-a clinical pathologic study. J Rheumatol 1983; 10:973-976.
16. Ernest D, Leung A: Ventilatory failure in shrinking lung syndrome is associated with reduced chest compliance. Intern Med J 2010; 40:66-68.
17. Cavallasca JA, Dubinsky D, Nasswetter GG: Shrinking lungs syndrome, a rare manifestation of systemic lupus erythematosus. Int J Clin Pract 2006; 60:1683-1686.
18. Bertsias GK, Salmon JE, Boumpas DT: Therapeutic opportunities in systemic lupus ery-thematosus: state of the art and prospects for the new decade. Ann Rheum Dis 2010; 69: 1603-1611.
19. Meijer JM, Meiners PM, Vissink A, Spijker-vet FK, Abdulahad W, Kamminga N, Brou-wer E, Kallenberg CG, Bootsma H: Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis R heum 2010; 62: 960-968.
20. Merrill JT, Neuwelt CM, Wallace DJ, Sha-nahan JC, Latinis KM, Oates JC, Utset TO, Gordon C, Isenberg DA, Hsieh HJ, Zhang D, Brunetta PG: Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum 2010; 62: 222-233.
21. Furie R, Looney RJ, Rovin B, Latinis KM, Appel G, Sanchez-Guerrero J, Fervenza FC: Efficacy and safety of rituximab in subjects with active proliferative lupus nephritis: results from the randomized, double-blind phase III lunar study. Arthritis Rheum 2009; 60:S429.
22. Lateef A, Petri M: Biologics in the treatment of systemic lupus erythematosus. Curr Opin R heumatol 2010; 22: 504-509.
23. Benham H, Garske L, Vecchio P, Eckert BW: Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheuma-tol 2010; 16:68-70.
24. Elkayam O, Segal R, Caspi D, Yaron M, Greif Y: Restrictive lung disease due to diaphragmatic dysfunction in systemic lupus erythematosus. Two case reports. Clin Exp R heumatol 1992; 10: 267-269.
25. Oud KT, Bresser P, ten Berge RJ, Jonkers RE: The shrinking lung syndrome in systemic lupus erythematosus: improvement with corticosteroid therapy. Lupus 2005; 14: 959-963.
26. Leandro MJ, Edwards JC, Cambridge G, Eh-renstein MR, Isenberg DA: An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 2673-2677.
27. Van Veen S, Peeters AJ, Sterk PJ, Breedveld FC: The 'shrinking lung syndrome' in SLE, treatment with theophylline. Clin Rheuma-tol 1993; 12:462-465.
28. Thompson PJ, Dhillon DP, Ledingham J, Turner-Warwick M: Shrinking lungs, diaphragmatic dysfunction, and systemic lupus er ythematosus. Am Rev Respir Dis 1985; 132: 926-928.
29. Stevens WM, Burdon JG, Clemens LE, Webb J: The 'shrinking lungs syndrome'-an infrequently recognised feature of systemic lupus erythematosus. Aust NZ J Med 1990; 20:67-70.
30. Soubrier M, Dubost JJ, Piette JC, Urosevic Z, Rami S, Oualid T, Ristori JM, Bussiere JL: Shrinking lung syndrome in systemic lupus erythematosus. A report of three cases. Rev Rhum Engl Ed 1995; 62: 395-398.
31. Munoz-Rodriguez FJ, Font J, Badia JR, Miret C, Barbera JA, Cervera R, Ingelmo M: Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled β-agonist therapy. Lupus 1997; 6:412-414.
32. Walz-Leblanc BA, Urowitz MB, Gladman DD, Hanly PJ: The 'shrinking lungs syndrome' in systemic lupus erythematosus-improvement with corticosteroid therapy. J Rheumatol 1992; 19: 1970-1972.
33. Branger S, Schleinitz N, Gayet S, Veit V, Ka-planski G, Badier M, Magnan A, Harle JR: Le syndrome des poumons rétractés et les maladies auto-immunes. Rev Méd Interne 2004; 25:83-90.